Hakuehdot

Kotisivu
Philips
EuroPCR

EuroPCR
The World-Leading Course in Interventional
Cardiovascular Medicine

    EuroPCR 2018

    Stay informed. Sign up now for cardiovascular news and updates.

    Contact us

    Highlights from EuroPCR 2018  

     

    Thanks for joining us at EuroPCR 2018! Check below our key highlights in pictures!

     

    We were highlighting our integrated solutions in image guided therapy and ultrasound that enable seamless cardiovascular care, helping clinicians to find the optimal pathways for better clinical outcomes, as well as lowering costs and increasing patient and staff satisfaction.

    Hot topics of the week included the Late-breaking trial: two-year clinical outcome data from SYNTAX II and the health economic data which demonstrates that an iFR-guided strategy reduces costs and improves patient comfort compared to an FFR-guided strategy, while delivering consistent cost savings and patient outcomes.

     

    On-site at EuroPCR Philips showcased its advanced interventional imaging systems, smart devices, planning and navigation software, and services, including:

     

    Azurion, Philips’ next generation image-guided therapy platform, which enables clinicians to easily and confidently perform a range of routine and complex procedures, helping them to optimize interventional lab performance and provide superior care. A recent study demonstrated the significant clinical workflow and staff experience benefits of the platform.

    iFR Roadmap [1] exclusive to Philips' interventional labs, enables physicians to navigate coronary arteries and corresponding iFR data in real time. 

    Philips’ SyncVision iFR co-registration solution, which couples iFR physiology measurement pull-back results to the coronary angio and can be utilized in the stenting process when lesions are more complex.

       

    No silos. No limits.

    When it comes to health, people deserve the best. Yet despite advances, progress is too often slowed. By systems that can’t communicate. By data that gets locked in silos. By clinicians who can’t see the full picture fast enough and patients who feel lost in the system. 

     

    At Philips, we collaborate on designing innovations to seamlessly bring together people, data and technology for personalized, actionable insights. This results in bringing cardiovascular care professionals and their patients together through the integration of data and targeted information across the care continuum. 

     

    We aim to deliver seamless cardiovascular care and improved workflows to reduce variation in the standard of care, and to find the optimal pathways for better clinical outcomes, lower costs, and increased patient and staff satisfaction – that’s health with no bounds.

    Guiding tomorrow's innovation
    Toistaminen
    Watch the video and see how Philips is removing the bounds of care

    Yhteystiedot

    * Tämä kenttä on pakollinen
    *

    Yhteystiedot

    *
    *
    *

    Yrityksen tiedot

    *
    *

    Mitä tämä tarkoittaa?

    How do you want to explore Philips Azurion?

     

    At EuroPCR you will be able to visit the Philips Azurion Experience at our booth F18 on level 1.

    Experience Azurion
    Azurion Experience Imac

    Please complete the form below to receive the EuroPCR symposia recording

    Yhteystiedot

    * Tämä kenttä on pakollinen
    *

    Yhteystiedot

    *
    *
    *

    Yrityksen tiedot

    *
    *

    Mitä tämä tarkoittaa?

    Proven outcomes.1,2 Superior value.1,3

     

    Health economic data from the DEFINE FLAIR trial demonstrates an iFR-guided strategy offers reduced costs and improved care compared to an FFR-guided strategy.

    Study result

    Proven outcomes

     
    • Validated in more than 4,500 patients1,2
    • Consistent outcomes as with FFR
    • 0.89 cut-point backed by data1,2,4
    Graphics

    Superior value

     
    • 10% Cost saving per patient
    • 10% reduction in procedure time
    • 90% reduction in patient discomfort1
    Graphic cluster

    1. Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFRand FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017 

    2. Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017

    3. Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.  

    4. An iFR cut-point of 0.89 matches best with an FFR ischemic cut-point of 0.80 with a specificity of 87.8% and sensitivity of 73.0%. (From ADVISE II, and iFR Operator’s Manual 505-0101.23)

    FootnotesLue vähemmän

    Explore our solutions and products across the care continuum

    Philips Interventional Hemodynamic system

    Monitor – Measure – Record

     

    Improving workflow in the interventional lab

    • New user interface designed to simplify hemodynamic monitoring and assessment
    • Improved communication in the lab by visualizing the analysis performed in the control room in the exam room
    • Enhance workflow through integrated iFR* and FFR modality
    • Developed to be confidently used by all staff members with minimal training

    Disclaimer:

    * iFR option is considered work in progress and is not CE marked and not available for sale.

    FootnotesLue vähemmän
    hemossystem
    IntelliSpace Cardiovascular empowers our care teams with integrated, comprehensive data within one system that arms them with the relevant actionable data.
    Learn more
    Guiding tomorrow's innovation
    Toistaminen

    What's trending

    Press inquiries:

     

    For EuroPCR, Press Inquiries, please contact

     

    Fabienne van der Feer

    fabienne.van.der.feer@philips.com

    Twitter: @FC_Feer  

     

    News

    News

    @PhilipsLiveFrom

    Read more

    By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.

    I understand